title: Negative CDX2 expression can be an important predictive and prognostic biomarker in stage II colon cancer.
authors.affiliation: Yildirim Beyazit University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.
authors.forename: Burak
authors.initials: B
authors.lastname: Bilgin
authors.forename: Mehmet A
authors.initials: MA
authors.lastname: Sendur
authors.forename: Muhammed B
authors.initials: MB
authors.lastname: Akinci
authors.forename: Bulent
authors.initials: B
authors.lastname: Yalcin
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D000071616:CDX2 Transcription Factor / Q000032:analysis*; D003110:Colonic Neoplasms / Q000737:chemistry / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology; D053843:DNA Mismatch Repair; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D000071616:CDX2 Transcription Factor; C491270:CDX2 protein, human